Presentation

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

Presenter: Lucas Boersma

May 18, 2017

REGISTER for free or LOG IN to view this content

Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial

Coronary

CAD Pharma

Structural Heart

Aortic Valve

Presentation

EuroPCR 2017

TAVR

Up Next

Presentation

Interaction Effects of Race/Ethnicity and Sex on Outcomes After PCI

May 18, 2017

More slides +

Presentation

Routine Fractional Flow Reserve Measurement after Percutaneous Coronary Intervention The FFR-SEARCH Study

Presenter: Roberto Diletti

May 18, 2017

Presentation

Neurological Complications After Transcatheter Aortic Valve Implantation

Presenter: Pieter Kappetein

May 18, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.